David S Snyder insider trades: Coya Therapeutics (COYA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | COYA | ↑ Buy | 1,800 | $7.19 | $13K | Direct | Nov 14, 2024 (0d) |
| Mar 12, 2020 | XCUR | ↑ Buy | 18,248 | $1.40 | $26K | Direct | Mar 16, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David S Snyder's insider trades
David S Snyder is Chief Financial Officer at Coya Therapeutics (COYA). Since Mar 12, 2020, David has reported 2 open-market purchases worth $39K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COYA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.